Free Trial

American Assets Investment Management LLC Acquires 100,000 Shares of Vivmark Residential Common Shares of Beneficial Interest $VMRK

Key Points

  • American Assets Investment Management opened a position in Vivmark Residential, buying 100,000 shares worth approximately $6.08 million during the third quarter.
  • Institutional investors and hedge funds own 92.68% of the stock. Company insiders sold 58,286 shares worth about $3.74 million over the past three months.
  • Analysts have a consensus Hold rating and a $71.42 target price. The company’s quarterly dividend is $0.7025 per share, equivalent to an annualized yield of 4.5%.
  • MarketBeat previews top five stocks to own in December.

American Assets Investment Management LLC bought a new position in shares of Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the company's stock, valued at approximately $6,076,000.

Several other large investors have also recently bought and sold shares of the stock. VestGen Advisors LLC increased its position in shares of Vivmark Residential Common Shares of Beneficial Interest by 4.7% during the third quarter. VestGen Advisors LLC now owns 5,048 shares of the company's stock valued at $307,000 after purchasing an additional 225 shares during the period. Planning Strategies Inc. lifted its position in Vivmark Residential Common Shares of Beneficial Interest by 87.5% in the third quarter. Planning Strategies Inc. now owns 538 shares of the company's stock worth $33,000 after purchasing an additional 251 shares during the period. Blume Capital Management Inc. acquired a new stake in Vivmark Residential Common Shares of Beneficial Interest during the third quarter worth $25,000. Rosenberg Matthew Hamilton boosted its stake in Vivmark Residential Common Shares of Beneficial Interest by 47.8% during the third quarter. Rosenberg Matthew Hamilton now owns 1,301 shares of the company's stock worth $79,000 after buying an additional 421 shares in the last quarter. Finally, Physician Wealth Advisors Inc. bought a new stake in Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $27,000. 92.68% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Vivmark Residential Common Shares of Beneficial Interest news, Director Christopher B. Howard sold 8,486 shares of the business's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $64.00, for a total value of $543,104.00. Following the transaction, the director owned 12,730 shares of the company's stock, valued at approximately $814,720. The trade was a 40.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Chris Carr sold 1,130 shares of the stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $65.28, for a total value of $73,766.40. Following the sale, the director owned 4,461 shares in the company, valued at $291,214.08. The trade was a 20.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 58,286 shares of company stock worth $3,735,822. 1.20% of the stock is currently owned by insiders.

Vivmark Residential Common Shares of Beneficial Interest Stock Down 0.5%

NYSE:VMRK opened at $61.93 on Wednesday. The firm has a market capitalization of $23.22 billion, a price-to-earnings ratio of 26.70, a PEG ratio of 3.61 and a beta of 0.72. Vivmark Residential Common Shares of Beneficial Interest has a 12 month low of $57.57 and a 12 month high of $71.50. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.19 and a current ratio of 0.19. The company has a 50-day moving average price of $62.70.

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $0.30 earnings per share for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a net margin of 27.97% and a return on equity of 8.06%. The company had revenue of $785.05 million during the quarter. On average, research analysts expect that Vivmark Residential Common Shares of Beneficial Interest will post 4.07 EPS for the current fiscal year.

Vivmark Residential Common Shares of Beneficial Interest Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 16th. Investors of record on Monday, October 5th were issued a dividend of $0.7025 per share. This represents a $2.81 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date of this dividend was Monday, October 5th. Vivmark Residential Common Shares of Beneficial Interest's dividend payout ratio (DPR) is currently 122.17%.

Wall Street Analysts Forecast Growth

VMRK has been the topic of several recent research reports. UBS Group decreased their target price on shares of Vivmark Residential Common Shares of Beneficial Interest from $75.00 to $71.00 and set a "buy" rating on the stock in a research report on Wednesday, October 14th. Royal Bank Of Canada dropped their price target on shares of Vivmark Residential Common Shares of Beneficial Interest from $71.00 to $67.00 and set a "sector perform" rating for the company in a research report on Tuesday, October 13th. KeyCorp started coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a research note on Wednesday, August 26th. They set a "sector weight" rating for the company. Wells Fargo & Company decreased their price objective on Vivmark Residential Common Shares of Beneficial Interest from $72.00 to $68.00 and set an "overweight" rating on the stock in a report on Monday, October 19th. Finally, Scotiabank decreased their price objective on Vivmark Residential Common Shares of Beneficial Interest from $70.00 to $66.00 and set a "sector perform" rating on the stock in a report on Thursday, September 17th. Five investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, Vivmark Residential Common Shares of Beneficial Interest has a consensus rating of "Hold" and a consensus target price of $71.42.

Check Out Our Latest Report on Vivmark Residential Common Shares of Beneficial Interest

Vivmark Residential Common Shares of Beneficial Interest Profile

(Free Report)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.

Read More

Want to see what other hedge funds are holding VMRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK - Free Report).

Institutional Ownership by Quarter for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vivmark Residential Common Shares of Beneficial Interest Right Now?

Before you consider Vivmark Residential Common Shares of Beneficial Interest, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivmark Residential Common Shares of Beneficial Interest wasn't on the list.

While Vivmark Residential Common Shares of Beneficial Interest currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines